Divergent expression changes of telomerase and E6/E7 mRNA, following integration of human papillomavirus type 33 in cultured epithelial cells
暂无分享,去创建一个
[1] L. Turek,et al. Telomerase activation in cervical keratinocytes containing stably replicating human papillomavirus type 16 episomes. , 2002, Virology.
[2] J. Choe,et al. Human Papillomavirus E2 Down-regulates the Human Telomerase Reverse Transcriptase Promoter* , 2002, The Journal of Biological Chemistry.
[3] S. Syrjänen,et al. Single copy heterozygote integration of HPV 33 in chromosomal band 5p14 is found in an epithelial cell clone with selective growth advantage. , 2002, Carcinogenesis.
[4] R. Schlegel,et al. Cervical epithelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity. , 2002, The American journal of pathology.
[5] D. Galloway,et al. E Box-Dependent Activation of Telomerase by Human Papillomavirus Type 16 E6 Does Not Require Induction of c-myc , 2001, Journal of Virology.
[6] L. Laimins,et al. Telomerase Activation by Human Papillomavirus Type 16 E6 Protein: Induction of Human Telomerase Reverse Transcriptase Expression through Myc and GC-Rich Sp1 Binding Sites , 2001, Journal of Virology.
[7] T. Veldman,et al. Transcriptional Activation of the Telomerase hTERT Gene by Human Papillomavirus Type 16 E6 Oncoprotein , 2001, Journal of Virology.
[8] D. Swinkels,et al. Real-time hTERT quantification: a promising telomerase-associated tumor marker. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[9] S. Sukumar,et al. Applications of telomerase research in the fight against cancer. , 1999, Molecular medicine today.
[10] T. Kiyono,et al. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells , 1998, Nature.
[11] J. Shay,et al. A survey of telomerase activity in human cancer. , 1997, European journal of cancer.
[12] J. McDougall,et al. Telomerase activation by the E6 gene product of human papillomavirus type 16 , 1996, Nature.
[13] P. Lambert,et al. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] C B Harley,et al. Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.
[15] A. Sajantila,et al. Isolation of two keratinocyte cell lines derived from HPV‐positive dysplastic vaginal lesions , 1992, International journal of cancer.
[16] C. Meijer,et al. Human papillomavirus type 33 in a tonsillar carcinoma generates its putative E7 mRNA via two E6* transcript species which are terminated at different early region poly(A) sites , 1992, Journal of virology.
[17] P. Howley,et al. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[18] G. Morin. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats , 1989, Cell.
[19] Carol W. Greider,et al. Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.
[20] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[21] June Corwin,et al. Telomerase Catalytic Subunit Homologs from Fission Yeast and Human , 1997 .
[22] J. Shay,et al. Telomerase activity in human germline and embryonic tissues and cells. , 1996, Developmental genetics.